PHILADELPHIA, Sept. 4 PA-Premier-Resrch-Dir
PHILADELPHIA, Sept. 4 /PRNewswire/ -- Premier Research Group Limited, the
international pharmaceutical services group, announces the appointment of
Fabio Trave, MD as Executive Director of Medical Affairs and Strategic Product
Development. In this position, Dr. Trave will expand Premier Research's
capabilities in the area of drug development consulting and strengthen
capabilities in the oncology therapeutic area. Dr. Trave also brings to the
organization significant expertise in the area of risk management and
pharmacovigilance. Dr. Trave will be based in our Milan office.
Dr. Trave has extensive experience working for both North American and
European-based pharmaceutical companies, including Farmitalia Carlo Erba,
Warner Lambert Parke-Davis, Pharmacia Corporation, and Bristol Myers Squibb,
where he was most recently responsible for pharmacovigilance activities in
Europe, Middle East, and Africa. He received his medical degree from the
University of Milan School of Medicine and completed his post-graduate
training in Clinical Oncology at the Italian National Cancer Institute in
Genoa and Experimental Therapeutics at Roswell Park Memorial Institute in
Buffalo, NY.
"We are very pleased to have Dr. Trave join our Medical Affairs team of
therapeutic experts," commented Dr. Samer Kaba, Vice President of Global
Medical Affairs and SPD. "His global perspective and diverse expertise will
strengthen our department and help us to expand our drug development and risk
management consulting services to meet the evolving needs of our clients."
About Premier Research
Premier Research is a leading solutions-driven CRO committed to
therapeutic focus and operational expertise to deliver clinical trial services
of the highest quality for biopharmaceutical and medical device companies.
They are leaders in clinical research for Analgesia, CNS, Infectious Disease,
and Oncology and have a wealth of experience in medical device and pediatric
research.
Premier Research has 30 offices and operates in more than 30 countries
across Europe and North America. Premier Research employs more than 1,200
clinical professionals dedicated first and foremost to fulfilling each
client's requirements in a timely, accurate, and cost-effective manner. This
includes a strong international network of monitors and project management
professionals combined with regulatory, data management, statistical,
scientific and medical experts, and staff at our well-established network of
dedicated clinical sites.
www.premier-research.com
SOURCE Premier Research Group Limited
